Drugs / Kalcipos-D
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02457247 | Jun → Aug 2015 | nutritional disorder | Takeda | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Kalcipos-D | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02457247 ↗ |
| Route | Oral | “Kalcipos-D (Calcium 500 mg/800 IU Vitamin D3), chewable tablets, orally, once, daily, on Days 1 through 14, followed by, Calcichew D3 500/800 (Calcium 500 mg/800 IU Vitamin...” NCT02457247 ↗ |